4//SEC Filing
Weinberg Uri 4
Accession 0001562180-25-001977
CIK 0001645113other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 4:19 PM ET
Size
5.9 KB
Accession
0001562180-25-001977
Insider Transaction Report
Form 4
NovoCure LtdNVCR
Weinberg Uri
Chief Innovation Officer
Transactions
- Sale
Ordinary Shares
2025-03-03$18.92/sh−268$5,071→ 166,243 total
Footnotes (2)
- [F1]Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units. This sale is mandated by the issuer's award agreement under its equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the reporting person.
- [F2]On the transaction date, the reporting person sold 268 shares in multiple trades at prices ranging from $18.8304 to $18.94. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide to the Staff, the issuer for any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
NovoCure Ltd
CIK 0001645113
Entity typeother
Related Parties
1- filerCIK 0001811030
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 4:19 PM ET
- Size
- 5.9 KB